SINTX Technologies Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
41
- Stock Symbol
-
SINT
- Investments
-
3
- Share Price
-
$3.55
- (As of Wednesday Closing)
SINTX Technologies General Information
Description
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
Contact Information
Website
www.sintx.comCorporate Office
- 1885 West 2100 South
- Salt Lake City, UT 84119
- United States
Corporate Office
- 1885 West 2100 South
- Salt Lake City, UT 84119
- United States
SINTX Technologies Timeline
SINTX Technologies Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.55 | $3.75 | $2.75 - $188.00 | $2.65M | 747K | 1.21M | -$1.98K |
SINTX Technologies Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 1,481 | (2,680) | 3,018 | 1,684 |
| Revenue | 1,438 | 1,226 | 601 | 606 |
| EBITDA | (6,950) | (6,735) | (11,082) | (8,735) |
| Net Income | (8,601) | (8,259) | (12,039) | (9,309) |
| Total Assets | 15,296 | 15,365 | 15,773 | 21,840 |
| Total Debt | 4,164 | 4,245 | 2,887 | 2,907 |
SINTX Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SINTX Technologies Comparisons
Industry
Financing
Details
000000
000000
SINTX Technologies Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CeramTec | Private Equity-Backed | Plochingen, Germany | 0000 | 00000000000 | ||
| Medtronic | Corporation | Minneapolis, MN | 00000 | 00.000 | 000000000 00 | 00.000 |
| Invibio | Corporation | Lancashire, United Kingdom | 00 | |||
| Smith & Nephew | Corporation | Watford, United Kingdom | 00000 | 000 | 000000000 00 | 000 |
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | 00000 | 00.000 | 000000000000 | 00.000 |
SINTX Technologies Patents
SINTX Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230093682-A1 | Methods for manufacturing silicon nitride materials | Pending | 22-Sep-2021 | 0000000000 | |
| EP-4404875-A1 | Methods for manufacturing silicon nitride materials | Pending | 22-Sep-2021 | 0000000000 | |
| AU-2022254712-A1 | Systems and methods for physical vapor deposition of silicon nitride coatings having antimicrobial and osteogenic enhancements | Pending | 07-Apr-2021 | 00000000000 | |
| US-20220322676-A1 | Systems and methods for physical vapor deposition of silicon nitride coatings having antimicrobial and osteogenic enhancements | Pending | 07-Apr-2021 | 00000000000 | 0 |
| EP-4320285-A1 | Systems and methods for physical vapor deposition of silicon nitride coatings having antimicrobial and osteogenic enhancements | Pending | 07-Apr-2021 | H01J37/3405 |
SINTX Technologies Executive Team (19)
| Name | Title | Board Seat |
|---|---|---|
| Eric Olson | Chief Executive Officer & President | |
| David O'Brien | Chief Operating Officer | |
| Michael Marcroft | Vice President of Sales and Marketing |
SINTX Technologies Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| B. Sonny Bal Ph.D | Self | Chairman of the Board, Chief Executive Officer, President and Principal Financial Officer | 000 0000 |
| David Truetzel | Self | Board Member | 000 0000 |
| Eric Stookey | Self | Board Member | 000 0000 |
| Jeffrey White | Self | Board Member | 000 0000 |
| Mark Froimson MD | Self | Board Member | 000 0000 |
SINTX Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SINTX Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SINTX Technologies Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Technology Assessment & Transfer | 30-Jun-2022 | 0000000000 | 00000 | Other Commercial Services | 0. 00000 |
| B4C (Ballistic Armor Plates Manufacturing Equipment and Technical Processes) | 22-Jul-2021 | 000000000 | Buildings and Property | 0. 00000 | |
| U.S. Spinal Technologies | 20-Sep-2010 | Merger/Acquisition | Therapeutic Devices |
SINTX Technologies Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Technology Assessment & Transfer | Other Commercial Services | Millersville, MD | 0000 |
SINTX Technologies FAQs
-
When was SINTX Technologies founded?
SINTX Technologies was founded in 1996.
-
Who is the CEO of SINTX Technologies?
Eric Olson is the CEO of SINTX Technologies.
-
Where is SINTX Technologies headquartered?
SINTX Technologies is headquartered in Salt Lake City, UT.
-
What is the size of SINTX Technologies?
SINTX Technologies has 41 total employees.
-
What industry is SINTX Technologies in?
SINTX Technologies’s primary industry is Other Commercial Products.
-
Is SINTX Technologies a private or public company?
SINTX Technologies is a Public company.
-
What is SINTX Technologies’s stock symbol?
The ticker symbol for SINTX Technologies is SINT.
-
What is the current stock price of SINTX Technologies?
As of 18-Sep-2024 the stock price of SINTX Technologies is $3.55.
-
What is the current market cap of SINTX Technologies?
The current market capitalization of SINTX Technologies is $2.65M.
-
What is SINTX Technologies’s current revenue?
The trailing twelve month revenue for SINTX Technologies is $1.44M.
-
Who are SINTX Technologies’s competitors?
CeramTec, Medtronic, Invibio, Smith & Nephew, and Zimmer Biomet Holdings are some of the 7 competitors of SINTX Technologies.
-
What is SINTX Technologies’s annual earnings per share (EPS)?
SINTX Technologies’s EPS for 12 months was -$1.98K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
